MedTrace Logo

Rhythm Training of a Serious Game on the Reading Skills of Children w/ a Specific Learning Disorder Impacting Reading

NCT05154721 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 151

Last updated 2023-07-18

No results posted yet for this study

Summary

Mila-Learn-01 is a double-blind clinical study (meaning that neither the patient nor the doctor or his/her team will know which game the child has), which enables us to see the effect of a serious game on the child's reading skills.

The patients who will participate in this research will receive, at random, one of the two serious study games, the experimental game (Mila-Learn) or the placebo game (Mila-Placebo). The tasks designed in the placebo game mirror those of Mila-Learn.

Each game comprises eight tasks to be completed on a touchscreen tablet. Each session lasts 25 minutes (±20%); five training sessions lasting 25 minutes are planned per week for eight weeks.

Conditions

  • Learning Disorder, Specific
  • Learning Disabilities
  • Dyslexia
  • Specific Learning Disorder, With Impairment in Reading

Interventions

DEVICE

experimental Group - Mila-Learn

Eight tasks are used in Mila-Learn.

DEVICE

control Group - Mila-Placebo

Eight tasks similar to Mila-Learn are used in the placebo group

Sponsors & Collaborators

  • Poppins

    lead INDUSTRY

Principal Investigators

  • David COHEN, Dr · Hôpital Pitié-Salpêtrière

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2023-04-03
Completion
2023-04-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05154721 on ClinicalTrials.gov